Testing effectiveness (Phase 2)Study completedNCT01599949
What this trial is testing
Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy
Who this might be right for
Mantle Cell Lymphoma
Janssen Research & Development, LLC 120